Baloro, Leonida C.
HRN: 18-54-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2025
CEFTAZIDIME 1GM (VIAL)
02/27/2025
03/05/2025
IV
1 Gram
Q 8 Hours
Tb
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes